跳至主要内容
临床试验/IRCT20170807035551N2
IRCT20170807035551N2招募中3 期

Efficacy of Tadalafil on improvement of erectile dysfunction caused by Covid 19

rology Research Center of Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 50 years(—)
性别
Male

入选标准

  • Erectile dysfunction after recovery from C0VID19
  • Men between the ages of 30 and 50
  • Obtaining patient consent

排除标准

  • History of erectile dysfunction before COVID19
  • History of trauma or anatomical problems in the penis
  • A history of neurological disorders including spinal cord injury, stroke, and migraine
  • History of heart disease
  • History of taking mineral nitrate drugs

研究者

发起方
rology Research Center of Tehran University of Medical Sciences

相似试验